Rare
lephants
Screener
Toggle theme
SAB Biotherapeutics, Inc.
SABS
·
Healthcare, Drug Manufacturers - General, United States
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
Cash Flow History
Net Cash Flow Breakdown
Net Cash Flow
Cash Flow
›
Net Cash Flow Breakdown
Net Cash Flow Breakdown
Chart
Table
FY2021
FY2020
Total Cash from Operations:
$39.7M
Line Item
Value
% of Total
Capital Expenditures
$10.9M
27.6%
Working Capital
$1.8M
4.6%
Net Cash Flow
$26.9M
67.9%
Download CSV
